These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4741936)

  • 1. Antitumor activity of N6-phenyladenosine, and inhibitor of adenosine utilization, in combination with related purine analogs.
    Grindey GB; Divekar AY; Hakala MT
    Cancer Res; 1973 Oct; 33(10):2459-63. PubMed ID: 4741936
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
    Chabner BA; Chello PL; Bertino JR
    Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of activity of beta-2'-deoxythioguanosine against two tumors resistant to 6-thioguanine.
    Nelson JA; Kuhns JN; Carpenter JW
    Cancer Res; 1975 May; 35(5):1372-4. PubMed ID: 1168098
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental studies on the antitumor effect of ethidium bromide and related substances.
    Nishiwaki H; Miura M; Imai K; Ono R; Kawashima K
    Cancer Res; 1974 Oct; 34(10):2699-703. PubMed ID: 4413384
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of interferon antitumor action by sodium butyrate.
    Bourgeade MF; Cerutti I; Chany C
    Cancer Res; 1979 Nov; 39(11):4720-3. PubMed ID: 498098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening study on Taiwan plants for antitumor activities.
    King ML; Wang CT; Chang CF; Hsu HM; Wang SJ; Hartwell JL; Abbott BJ
    Cancer Chemother Rep 2; 1974 Jul; 4(3):1-96. PubMed ID: 4842546
    [No Abstract]   [Full Text] [Related]  

  • 7. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T; Akahori Y; Sakurai Y
    Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor chemotherapy. Considerations on the potential role of immunity].
    Mihich E
    Pathol Biol; 1967 Feb; 15(3):209-14. PubMed ID: 4860732
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of some sulfhydryl compounds on the antineoplastic effectiveness of 5-fluorouracil and 6-mercaptopurine.
    Danysz A; Wierzba K; Wutkiewicz M; Pniewska A; Pragłowski T; Burba-Anczewska I
    Arch Immunol Ther Exp (Warsz); 1984; 32(3):345-9. PubMed ID: 6395826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between the antiproliferative activities of arabinosyladenine and N6-benzyladenosine.
    Tritsch GL; Nechaev A; Mittelman A
    Cancer Biochem Biophys; 1977; 2(2):87-90. PubMed ID: 567524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical mechanisms for the synergism between 6-thioguanine and 6-(methylmercapto)purine ribonucleoside in sarcoma 180 cells.
    Nelson JA; Parks RE
    Cancer Res; 1972 Oct; 32(10):2034-41. PubMed ID: 4673141
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin.
    Cass CE; Selner M; Tan TH; Muhs WH; Robins MJ
    Cancer Treat Rep; 1982 Feb; 66(2):317-26. PubMed ID: 6976834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the antitumor effect of 6-mercaptopurine by vitamin A.
    Akiyama S; Masuda A; Tabuki T; Kuwano M; Komiyama S
    Gan; 1981 Oct; 72(5):742-6. PubMed ID: 7199007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methanesulfonates: the relationship of structure to antitumor activity.
    Sandberg JS; Wood HB; Engle RR; Venditti JM; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):137-229. PubMed ID: 4350012
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of drug combination of antitumor activity and myelotoxicity.
    Fujimoto S; Inouye T; Tsukagoshi S
    Gan; 1976 Apr; 67(2):207-14. PubMed ID: 964553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the antineoplastic action of N-methylisoindigotin].
    Ji XJ; Zhang FR; Liu Y; Gu QM
    Yao Xue Xue Bao; 1985 Apr; 20(4):247-51. PubMed ID: 4072694
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicological and antiproliferative effects of N6-(delta2-isopentenyl) adenosine, a natural component of mammalian transfer RNA.
    Suk D; Simpson CL; Mihich E
    Cancer Res; 1970 May; 30(5):1429-36. PubMed ID: 5426945
    [No Abstract]   [Full Text] [Related]  

  • 20. The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.
    Sartorelli AC; Booth BA
    Cancer Res; 1965 Oct; 25(9):1393-400. PubMed ID: 5861069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.